Factors Associated with Ischaemic Stroke Development Despite Oral Anticoagulant Therapy in Patients with Non-Valvular Atrial Fibrillation

dc.contributor.authorOzdemir, Emre
dc.contributor.authorTiryaki, Muhammed Mucahit
dc.contributor.authorEmren, Zeynep
dc.contributor.authorSafak, Ozgen
dc.contributor.authorTiryaki, Enise
dc.contributor.authorEkinci, Aysen Suzen
dc.date.accessioned2025-07-03T21:25:28Z
dc.date.issued2025
dc.departmentBalıkesir Üniversitesi
dc.description.abstractObjective: To evaluate the effectiveness of the most popular risk scores (CHADS2, CHA2DS2-VASc, and ATRIA scores) in predicting stroke events in patients with non-valvular atrial fibrillation (NVAF) who were already receiving oral anticoagulant therapy (OAT). Study Design: An observational study. Place and Duration of the Study: Department of Cardiology, Ataturk Research and Training Hospital, Izmir Katip Celebi University, Izmir, Turkiye, from January 2020 to December 2023. Methodology: Patients with NVAF who were on OAT were divided into two groups. Group 1 consisted of patients who had not experienced a stroke while on OAT, and Group 2 consisted of patients who had experienced at least one stroke while on OAT at the time of inclusion. Continuous variables were presented as mean or median values and were compared using Student's t-test or Mann-Whitney U test, depending on the type of data distribution. Results: There were 162 patients in Group 1 and 129 patients in Group 2, the majority being females. The median age of patients was 76 years (IQR: 71-82) in Group 1 and 75 years (IQR: 68-81) in Group 2. Comorbidities were statistically similar in both groups except for hyperlipidemia. Treatment for atrial fibrillation (AF) was also statistically similar in both groups. The CHA2DS2-VASc and ATRIA stroke scores showed statistically significant differences between the groups. In univariate analysis, hyperlipidemia and ATRIA stroke score were >8, and in multivariate analysis, only ATRIA stroke score was >8, which showed a correlation with estimating the risk of ischaemic stroke (IS) events under oral anticoagulation (OAC). The ATRIA stroke score showed a strong correlation Spearman's rho test and in the ROC curve. Conclusion: The CHA2DS2-VASc, CHADS, and ATRIA risk scores have proven effective in primary IS prophylaxis. The ATRIA stroke score system for secondary prevention appears to be more effective than the most popular score systems.
dc.identifier.doi10.29271/jcpsp.2025.06.712
dc.identifier.endpage716
dc.identifier.issn1022-386X
dc.identifier.issn1681-7168
dc.identifier.issue6
dc.identifier.pmid40491103
dc.identifier.scopus2-s2.0-105006947129
dc.identifier.scopusqualityQ2
dc.identifier.startpage712
dc.identifier.urihttps://doi.org/10.29271/jcpsp.2025.06.712
dc.identifier.urihttps://hdl.handle.net/20.500.12462/21494
dc.identifier.volume35
dc.identifier.wosWOS:001504585300008
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherColl Physicians & Surgeons Pakistan
dc.relation.ispartofJcpsp-Journal of the College of Physicians and Surgeons Pakistan
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250703
dc.subjectNon-valvular atrial fibrillation
dc.subjectATRIA stroke score
dc.subjectCHA2DS2-VASc
dc.subjectOral anticoagulation
dc.subjectIschaemic stroke
dc.titleFactors Associated with Ischaemic Stroke Development Despite Oral Anticoagulant Therapy in Patients with Non-Valvular Atrial Fibrillation
dc.typeArticle

Dosyalar